Ex-CEO Admits Securities Fraud In Fake COVID Test Case

By Mark Payne · December 8, 2023, 7:16 PM EST

A former biotech CEO pled guilty in D.C. federal court Thursday to charges of securities fraud, wire fraud and obstruction after he concocted a scheme to defraud investors by falsely telling...

To view the full article, register now.